A Year in Review

Monash IVF Group places great importance on partnering with doctors committed to delivering market-leading success rates and best-in-class patient experience.

Read More

Our Strategic Pillars

Doctor Partnerships

Doctor Partnerships

25 new doctors joined us during FY23. Additionally, our entry into the WA market means we are the only fertility provider with a presence in every mainland capital city.

Patient Experience

Our commitment to nurturing patient experiences continued with initiatives including a Group Nursing Advisory Committee, Best-in-Class Patient Experience training and refined patient journey processes.

Scientific Leadership

Monash IVF Group invests in innovative technology and research to ensure that we continue to provide market leading success rates for our patients.

International Expansion

Since FY20, Monash IVF Group has expanded in the Southeast Asian (SEA) region, building on the region’s first and only SEA IVF platform.

People Engagement

People Engagement

In FY23 we succeeded industry benchmarks with our highest recorded engagement score at Monash IVF Group of 64%, a 3% improvement on FY22.

Digital Transformation

Digital Transformation

As part of our plans in integrate digitisation of overall workflows and processes, our new patient management system will replace paperwork with an efficient, patient-centric experience.

Brand & Marketing

Brand & Marketing

As a purpose led organisation, we believe we have a role to play in creating a societal shift in how people think and behave in relation to their fertility.

Clinical Infrastructure

Clinical Infrastructure

Monash IVF Group has continued to invest in best-in-class clinical facilities and technology setting the foundations for growth.

Industry Growth Drivers

Along with the continued demand for Monash IVF Group’s services and treatments are a number of significant industry developments that indicate continued market growth.

Read More

Our 4 Year Metrics

Over the past four years, Monash IVF Group has remained at the forefront of our field and consistently achieved strong results across numerous key business areas.

Read More

Board of Directors
& Management team

Learn more about our Board of Directors
and Leadership team.

Read More

Financial Reports

We are pleased to have delivered a strong financial performance and growth in FY23 across Australia and South-East Asia, with strong patient pipelines leading into FY24.

Read More

Downloads

Annual
Report

Financial
Reports

Sustainability
Report